NLRP3 and allergic asthma: Studies have shown that RRx-001 significantly inhibits HDM-induced eosinophil, neutrophil, and lymphocyte infiltration of the airways and improves allergic asthma symptoms by inhibiting NLRP3 activation and eosinophilic airway inflammation (104).